Zitta Barrella H.
- Country
- Denmark
- Department
- Departement of respiratory and infectious diseases
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Respiratory Medicine and Infectious Pulmonary Diseases
The investigator concentrates on conditions affecting the airway and lung parenchyma, with a particular emphasis on viral and bacterial respiratory infections.
- Chronic Obstructive Pulmonary Disease
- Community‑acquired pneumonia
- Severe viral lung infections
- Chronic rhinosinusitis with nasal polyps
- Acute respiratory distress in critical care
Research includes evaluating anti‑inflammatory strategies, novel antimicrobial regimens, and vaccine‑induced innate immunity.
Cardiovascular and Heart Failure Therapeutics
Focused on diseases of the heart and vascular system, especially acute decompensated heart failure and atherosclerotic complications.
- Acute heart failure with pulmonary congestion
- Myocardial infarction
- Atrial fibrillation stroke prevention
- Fluid overload in intensive care
- Cardiovascular risk in chronic kidney disease
Investigations address optimal diuretic and vasodilator use, anticoagulant selection, and cardioprotective interventions.
Diabetes, Metabolic Disorders and Obesity
The investigator’s work spans type 1 and type 2 diabetes, associated metabolic complications, and weight‑management strategies.
- Type 1 diabetes
- Type 2 diabetes
- Diabetic Charcot foot
- Obesity and overweight
- Cardiovascular outcomes in diabetic populations
Key projects explore novel glucose‑lowering agents, bone health in diabetes, and combined diet‑exercise interventions.
Oncology – Breast Cancer and Targeted Therapies
Specialized in hormone‑receptor positive and triple‑negative breast cancer, with attention to metastatic disease and biomarker‑driven treatment.
- Hormone‑receptor positive, HER2‑negative breast cancer
- Triple‑negative breast cancer
- HER2‑positive breast cancer with brain metastasis
- Neoadjuvant chemotherapy augmentation
- Pathologic complete response as efficacy endpoint
Research evaluates combination regimens, novel kinase inhibitors, and strategies to improve survival outcomes.
Inflammatory Bowel Disease and Autoimmune Conditions
Engaged in the study of chronic intestinal inflammation and related autoimmune disorders, targeting disease remission and mucosal healing.
- Moderately to severely active Crohn’s disease
- Moderately to severely active ulcerative colitis
- Biologic therapy tapering strategies
- Systemic corticosteroid‑free remission
- Novel oral small‑molecule agents
Efforts include long‑term safety assessment of emerging therapeutics and optimization of treatment algorithms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.